Armata Pharmaceuticals

$3.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.00 (-0.03%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell ARMP and other stocks, options, and ETFs commission-free!

About ARMP

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA. The listed name for ARMP is Armata Pharmaceuticals, Inc. Common Stock.

CEO
Todd R. Patrick
Employees
38
Headquarters
Los Angeles, California
Founded
2019
Market Cap
58.80M
Price-Earnings Ratio
Dividend Yield
Average Volume
30.57K
High Today
$3.17
Low Today
$3.12
Open Price
$3.17
Volume
5.32K
52 Week High
$6.92
52 Week Low
$2.52

Collections

ARMP Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.31 per share

You May Also Like